← Back to Search

Immunotherapy

Boiled Peanut Powder for Peanut Allergy (BPOIT Trial)

Phase 1
Waitlist Available
Led By Jaclyn Bjelac, MD
Research Sponsored by Alton Melton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 weeks
Awards & highlights

BPOIT Trial Summary

This trial is testing whether boiled peanuts can help treat peanut allergies in children, and whether the treatment is better than a placebo.

Eligible Conditions
  • Peanut Allergy

BPOIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Increase in tolerance to peanut in pediatric patients with peanut hypersensitivity.

Side effects data

From 2012 Phase 2 & 3 trial • 4 Patients • NCT00090493
75%
DVT
75%
Staphyloccocal infections
25%
Shingles
100%
80%
60%
40%
20%
0%
Study treatment Arm
MAGE-A3 AND NY-ESO-1 IMMUNOTHERAPY

BPOIT Trial Design

1Treatment groups
Experimental Treatment
Group I: Boiled Peanut PowderExperimental Treatment1 Intervention
Boiled Peanut Powder

Find a Location

Who is running the clinical trial?

Alton MeltonLead Sponsor
The Cleveland ClinicOTHER
1,034 Previous Clinical Trials
1,365,415 Total Patients Enrolled
Jaclyn Bjelac, MDPrincipal InvestigatorStaff
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top